Академический Документы
Профессиональный Документы
Культура Документы
Immunotherapy Study
Immune checkpoints are regulators of the immune system. These pathways are crucial for self-
tolerance, which prevents the immune system from attacking cells indiscriminately. Inhibitory
checkpoint molecules have been increasingly considered as new targets for cancer immunotherapy
due to their potential for use in multiple types of cancers. To assist scientists in the field of immune-
oncology, Creative BioMart released a bunch of quality immune checkpoint proteins.
Immune checkpoints are regulators of immune activation. They play a key role in maintaining
immune homeostasis and preventing autoimmunity. In cancer, immune checkpoint mechanisms
are often activated to suppress the nascent anti-tumor immune response.
“We are quite pleased for the release of those immune checkpoint proteins for scientists in the
field of cancer immunotherapy research. We are always working to providing comprehensive and
quality products for our customers to accelerate their life science research, to solve complex
analytical challenges, and to increase laboratory productivity.” Commented Linna, the chief
marketing staff in Creative BioMart.
Upon this new launch, immune checkpoint proteins offerings in Creative BioMart include but are
not limited to: 2B4, 4-1BB, B7-1, B7-2, B7-H2, CD1155, CD160, CD19, CD200, CD27, CTLA-4, DNAM-
1, PD-1, PD-L1, PD-L2, PGK, TIM-3, GITR Ligand, HVEM, IDO1, TIM-3, CD-27 Ligand, etc.
To have a view of the whole list of immune checkpoint proteins provided by Creative BioMart, you
can visit https://www.creativebiomart.net/Immune-Checkpoint-Proteins.htm